This suggests that although tumor stage is a traditional indicator when predicting prognosis, the additional factors in our nomogram, IRGs signatures consisting CCL8 and DEFB1, and the age of patients, are also worth considering. This evidence concerns the gene DEFB1 and neoplasm.